Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Alexopoulos

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Reviews in Endocrine & Metabolic Disorders|July 3, 2016
Stress-related skin disordersAlex Alexopoulos, George P Chrousos
Pediatric Dermatology|November 15, 2013
Retrospective analysis of the relationship between infantile seborrheic dermatitis and atopic dermatitisAlex Alexopoulos, Talia Kakourou, Irene Orfanou, et al.
Pediatric Dermatology|August 30, 2022
A randomized, observer-blind, vehicle-control, multi-center clinical investigation for assessing the efficacy and tolerability of a 1% ectoine and hyaluronic acid 0.1%-containing medical device in pediatric patients with mild-to-moderate atopic dermatitisAlex Alexopoulos, Maria Dakoutrou, Lamprini Nasi, et al.
JAMA Dermatology|February 6, 2020
A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic AgentsInge M G J Bronckers, Amy S Paller, Dennis P West, et al.
JAMA Dermatology|September 14, 2017
Safety of Systemic Agents for the Treatment of Pediatric PsoriasisInge M G J Bronckers, Marieke M B Seyger, Dennis P West, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Reviews in Endocrine & Metabolic Disorders|July 3, 2016
Stress-related skin disordersAlex Alexopoulos, George P Chrousos
Pediatric Dermatology|November 15, 2013
Retrospective analysis of the relationship between infantile seborrheic dermatitis and atopic dermatitisAlex Alexopoulos, Talia Kakourou, Irene Orfanou, et al.
Pediatric Dermatology|August 30, 2022
A randomized, observer-blind, vehicle-control, multi-center clinical investigation for assessing the efficacy and tolerability of a 1% ectoine and hyaluronic acid 0.1%-containing medical device in pediatric patients with mild-to-moderate atopic dermatitisAlex Alexopoulos, Maria Dakoutrou, Lamprini Nasi, et al.
JAMA Dermatology|February 6, 2020
A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic AgentsInge M G J Bronckers, Amy S Paller, Dennis P West, et al.
JAMA Dermatology|September 14, 2017
Safety of Systemic Agents for the Treatment of Pediatric PsoriasisInge M G J Bronckers, Marieke M B Seyger, Dennis P West, et al.
Pageof 1